Treatment of Transmissible Spongiform Encephalopathy by Intraventricular Drug Infusion in Animal Models

Journal of Virology

Volumn 78, Issue 10, 2004, Pages 4999-5006

  Doh Ura, Katsumi ^a,c   Ishikawa, Kensuke ^a,c   Murakami Kubo, Ikuko ^a   Sasaki, Kensuke ^a   Mohri, Shirou ^a   Race, Richard ^b   Iwaki, Toru ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; MEPACRINE; PENTOSAN POLYSULFATE; PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; HEMATOMA; HEMISPHERE; INCUBATION TIME; MOUSE; NERVE DEGENERATION; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; SCRAPIE; VIRUS INFECTIVITY;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; MICE; PENTOSAN SULFURIC POLYESTER; PRION DISEASES; PRIONS;

EID: 2342623474     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.10.4999-5006.2004     Document Type: Article

References (22)

1. Barret, A., F. Tagliavini, G. Forloni, C. Bate, M. Salmona, L. Colombo, A. De Luigi, L. Limido, S. Suardi, G. Rossi, F. Auvré, K. T. Adjou, N. Salés, A. Williams, C. Lasmézas, and J. P. Deslys. 2003. Evaluation of quinacrine treatment for prion diseases. J. Virol. 77:8462-8469.
2. Brown, P. 2002. Drug therapy in human and experimental transmissible spongiform encephalopathy. Neurology 58:1720-1725.
3. Brown, P., M. Preece, J. P. Brandel, T. Sato, L. McShane, I. Zerr, A. Fletcher, R. G. Will, M. Pocchiari, N. R. Cashman, J. H. d'Aignaux, L. Cervenakova, J. Fradkin, L. B. Schonberger, and S. J. Collins. 2000. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 55:1075-1081.
4. Caughey, B., K. Brown, G. J. Raymond, G. E. Katzenstein, and W. Thresher. 1994. Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and Congo red. J. Virol. 68:2135-2141.
5. Caughey, B., and G. J. Raymond. 1993. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J. Virol. 67:643-650.
6. Collins, S. J., V. Lewis, M. Brazier, A. F. Hill, A. Fletcher, and C. L. Masters. 2002. Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model. Ann. Neurol. 52:503-506.
7. Dealler, S. 1998. Post-exposure prophylaxis after accidental prion inoculation. Lancet 351:600.
8. Demaimay, R., K. T. Adjou, V. Beringue, S. Demart, C. I. Lasmézas, J. P. Deslys, M. Seman, and D. Dormont. 1997. Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals. J. Virol. 71:9685-9689.
9. Diringer, H., and B. Ehlers. 1991. Chemoprophylaxis of scrapie in mice. J. Gen. Virol. 72:457-460.
10. Doh-ura, K., T. Iwaki, and B. Caughey. 2000. Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J. Virol. 74:4894-4897.
11. Doh-ura, K., E. Mekada, K. Ogomori, and T. Iwaki. 2000. Enhanced CD9 expression in the mouse and human brains infected with transmissible spongiform encephalopathies. J. Neuropathol. Exp. Neurol. 59:774-785.
12. Ehlers, B., and H. Diringer. 1984. Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen. J. Gen. Virol. 65:1325-1330.
13. Farquhar, C., A. Dickinson, and M. Bruce. 1999. Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies. Lancet 353:117.
14. Fischer, M., T. Rulicke, A. Raeber, A. Sailer, M. Moser, B. Oesch, S. Brandner, A. Aguzzi, and C. Weissmann. 1996. Prion protein (PrP) with aminoproximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15:1255-1264.
15. Korth, C., B. C. May, F. E. Cohen, and S. B. Prusiner. 2001. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc. Natl. Acad. Sci. USA 98:9836-9841.
16. Ladogana, A., P. Casaccia, L. Ingrosso, M. Cibati, M. Salvatore, Y. G. Xi, C. Masullo, and M. Pocchiari. 1992. Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. J. Gen. Virol. 73:661-665.
17. Priola, S. A., B. Caughey, and W. S. Caughey. 1999. Novel therapeutic uses for porphyrins and phthalocyanines in the transmissible spongiform encephalopathies. Curr. Opin. Microbiol. 2:563-566.
18. Prusiner, S. B. 1998. Prions. Proc. Natl. Acad. Sci. USA 95:13363-13383.
19. Race, R. E., S. A. Priola, R. A. Bessen, D. Ernst, J. Dockter, G. F. Rail, L. Mucke, B. Chesebro, and M. B. Oldstone. 1995. Neuron-specific expression of a hamster prion protein minigene in transgenic mice induces susceptibility to hamster scrapie agent. Neuron 15:1183-1191.
20. Shyng, S. L., S. Lehmann, K. L. Moulder, and D. A. Harris. 1995. Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells. J. Biol. Chem. 270:30221-30229.
21. Will, R. G., J. W. Ironside, M. Zeidler, S. N. Cousens, K. Estibeiro, A. Alperovitch, S. Poser, M. Pocchiari, A. Hofman, and P. G. Smith. 1996. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921-925.
22. Wong, C., L. W. Xiong, M. Horiuchi, L. Raymond, K. Wehrly, B. Chesebro, and B. Caughey. 2001. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein. EMBO J. 20:377-386.